Navigation Links
QLT restructures Visudyne(R) agreement
Date:10/19/2009

directly influence Visudyne sales in the U.S. by establishing a small focused sales force centered on retinal specialists."

As part of the restructure, QLT and Novartis have released each other from all open claims the parties may have against each other, including any in connection with QLT's litigation with Massachusetts Eye and Ear Infirmary and QLT's litigation with General Hospital Corporation (doing business as Massachusetts General Hospital).

About Visudyne

Visudyne therapy is a two-step procedure involving the intravenous administration of the drug into the patient's arm. A non-thermal laser light is then shone into the patient's eye to activate the drug. This produces a reaction that closes the abnormal leaky vessels, resulting in a stabilization of the corresponding vision loss.

Visudyne is approved worldwide for the treatment of a form of wet AMD, the leading cause of legal blindness in people over the age of 55, and has been used in more than two million treatments worldwide. Visudyne is commercially available in more than 80 countries for the treatment of predominantly classic subfoveal CNV. In addition, over 60 countries have approved Visudyne to treat other macular neovascular conditions such as minimally classic and occult with no classic AMD lesions, pathological myopia and presumed ocular histoplasmosis.

About QLT

QLT Inc. is a global biopharmaceutical company dedicated to the discovery, development and commercialization of innovative ocular therapies. We utilize two unique technology platforms, photodynamic therapy (used with the Visudyne product) and punctal plugs, which are currently under development for future product opportunities. For more information, visit our website at www.qltinc.com.

Visudyne is a registered trademark of Novartis AG.

QLT Inc. is listed on The NASDAQ Stock Market under the trading symbol "QLTI
'/>"/>

SOURCE QLT Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Misonix Restructures and Expands Sales Organization in Europe
2. Medicsight PLC Restructures Management Team
3. Haemacure Restructures - Seeks Financing or Sale of the Company
4. eFoodSafety.com Restructures purEffect(TM) Marketing Agreement with CK41
5. NewCardio Restructures 2007 Financing, Receives $2.8 Million Additional Cash and Improves Capital Structure
6. VaxGen Restructures Following Termination of Proposed Merger
7. Pharmos Restructures Operations in Israel
8. QLT announces 12-month results from Novartis sponsored MONT BLANC study evaluating standard-fluence Visudyne(R) combination therapy
9. QLT announces positive results from the evaluation of Visudyne(R) combination therapy
10. QLT announces Visudyne(R) sales for fourth quarter and fiscal year 2008
11. QLT announces first quarter 2008 Visudyne(R) sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... January 22, 2015 The City of West Hollywood ... a.m., to commemorate the 42nd anniversary of the Supreme Court decision ... “It’s been 42 years since the Roe vs. Wade decision and ... as present as ever,” said City of West Hollywood Councilmember Abbe ...
(Date:1/22/2015)... TX (PRWEB) January 22, 2015 The Incredible ... Bodybuilder Ben Pakulski to increase lean muscle by up to ... has caught the attention of HealthyandFitZone.com’s Stan Stevenson, prompting an ... that it is a step-by-step, scientific diet formula that allows ...
(Date:1/22/2015)... Juvent Sports ( http://www.juventsports.com ) and David ... Show to bestow a Juvent Sports Achievement award upon ... McKitrick. The award commemorated and congratulated McKitrick for her ... won her first amateur tournament in 1979 and most ...
(Date:1/22/2015)... has released a new blog post presenting the basic features ... Purchasing an accidental death and dismemberment rider for a car ... provides benefits if the insured dies in an accident. Accidental ... life insurance. , AD&D is not expensive and can ...
(Date:1/22/2015)... IsoComforter, Inc. has introduced the most innovative and easy ... treat specific body parts and muscle groups. , IsoComforter, ... use patented cold therapy machine with the innovative IsoTube design ... injuries. IsoComforter has become the industry leader in cold ...
Breaking Medicine News(10 mins):Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2
... China, May 13 /PRNewswire-Asia-FirstCall/ -- Jiangbo,Pharmaceuticals, Inc., (OTC ... changed its name from Genesis Pharmaceuticals Enterprises,Inc., OTC ... its,principal operations in the People,s Republic of China, ... call at 9:30 a.m. Eastern on Tuesday, May,19, ...
... Ill., May 13 The American Massage Therapy Association(R) ... ,erotic services, section as an opportunity to clarify for ... are not massage therapists. "The public and massage ... massage should only be the right of massage therapists," ...
... cyclists, fans and anyone interested in fitness will have plenty ... up to the 24th Los Angeles Marathon to be held ... up:>> Saturday, May 23: Run/Ex/09 , One of the largest ... South Hall of the Los Angeles Convention Center. More than ...
... near the University of Washington and Montlake Bridge ... Nordstrom Beat the Bridge to Beat Diabetes 8K run, which ... , From 7:30 a.m. until 10:00 a.m., Montlake Boulevard ... NE. 520 Ramp Closures , From 8:15 ...
... the newest "Biggest Loser" but she is a real champion ... about simple, everyday choices that can help you be healthy ... glass and is one of the simplest things you can ... athletes to don a ,stache for the National Milk Mustache ...
... 13 Speaker Nancy Pelosi received an "Award ... today on future directions in the fight against HIV/AIDS. ... select individuals in recognition of the vision, determination, and ... against AIDS. Other 2009 awardees are Senator Edward Kennedy, ...
Cached Medicine News:Health News:Jiangbo Pharmaceuticals, Inc. Announces Conference Call to Discuss Results for its Third Quarter of FY 2009 2Health News:AMTA Applauds Craigslist Decision, Calls for Protection of Massage Therapists 2Health News:Full Calendar of Activities for 24th Los Angeles Marathon This Memorial Day Weekend 2Health News:Nordstrom Beat the Bridge to Beat Diabetes Run to Temporarily Suspend Traffic in University District on Sunday, May 17 2Health News:Pelosi Remarks at amfAR Conference on Future Directions in Fight Against HIV/AIDS 2
(Date:1/23/2015)... Feffer LLP ( www.hfesq.com ) is investigating potential claims ... or the "Company") (NASDAQ: ADXS ), concerning ... shareholders. On January 21, 2015, an article ... had misrepresented the clinical data for its ADXS-HPV drug ...
(Date:1/23/2015)... Companies, Inc. (ICBU) has repositioned itself as a holding company ... foothold in the hydroponic, hemp and medical marijuana sectors. By ... the sector, and recently partnering with the Chippewa Tribe Nation ... marijuana, iMD is committing to bring its vision to the ...
(Date:1/23/2015)... Jan. 23, 2015  CytoSorbents Corporation (NASDAQ CM: CTSO), ... extracorporeal cytokine adsorber to reduce deadly inflammation in ... of $385,642, net of transaction costs, in non-dilutive ... Business Tax Certificate Transfer Program sponsored by the ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3
... FRANCISCO, Calif., May 1, 2012  Rigel Pharmaceuticals, Inc. (Nasdaq: ... ended March 31, 2012. For the first quarter ... or $0.32 per share, compared to a net loss of ... of 2011. Weighted average shares outstanding for the first quarters ...
... (NYSE: SHP ) ("ShangPharma" or the ... and development outsourcing company, today announced that it ... for the year ended December 31, 2011 with ... "SEC"). The annual report can be accessed on ...
Cached Medicine Technology:Rigel Announces First Quarter 2012 Financial Results 2Rigel Announces First Quarter 2012 Financial Results 3Rigel Announces First Quarter 2012 Financial Results 4ShangPharma Corporation Files 2011 Annual Report on Form 20-F 2
Latex-free coronary artery perfusion/cardioplegia infusion cannulae....
... the clarity of daylight into the surgical ... Source. Designed for a variety of applications ... and video equipment - this light source ... watts (6,000o K) for superb tissue definition, ...
... the Novametrix' family of capnography products. Along ... are the only handheld, mainstream capnographs available ... patient's airway condition and ventilatory status. Based ... capnographs, we miniaturized the size, not the ...
Designed for simple operation, the Model 515B pulse oximeter is ideal for use in any clinical setting; from emergency hospital transport to continuous monitoring in Anesthesia, Intensive Care and Gen...
Medicine Products: